Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 259

1.

Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.

Asgari N, Skejoe HP, Lillevang ST, Steenstrup T, Stenager E, Kyvik KO.

BMC Neurol. 2013 Apr 8;13:33. doi: 10.1186/1471-2377-13-33.

2.

Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.

Bălaşa R, Maier S, Bajko Z, Motataianu A, Crişan A, Bălaşa A.

Acta Neurol Belg. 2015 Dec;115(4):635-42. doi: 10.1007/s13760-015-0479-z. Epub 2015 May 6. Review.

PMID:
25944511
3.

Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.

Pekcevik Y, Mitchell CH, Mealy MA, Orman G, Lee IH, Newsome SD, Thompson CB, Pardo CA, Calabresi PA, Levy M, Izbudak I.

Mult Scler. 2016 Mar;22(3):302-11. doi: 10.1177/1352458515591069. Epub 2015 Jul 24.

4.

Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies.

Chang KH, Lyu RK, Chen CM, Wu YR, Chang HS, Huang CC, Kuo HC, Chu CC, Hsu WC, Ro LS.

Mult Scler. 2013 Mar;19(3):299-307. doi: 10.1177/1352458512451659. Epub 2012 Jul 24.

PMID:
22829325
5.

Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

Kitley J, Leite MI, Küker W, Quaghebeur G, George J, Waters P, Woodhall M, Vincent A, Palace J.

JAMA Neurol. 2013 Nov;70(11):1375-81. doi: 10.1001/jamaneurol.2013.3890.

PMID:
23999580
6.

Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.

Carnero Contentti E, Hryb JP, Morales S, Gomez A, Chiganer E, Di Pace JL, Lessa C, Perassolo M.

J Neurol Sci. 2017 Feb 15;373:134-137. doi: 10.1016/j.jns.2016.12.033. Epub 2016 Dec 23.

PMID:
28131170
7.

Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.

Kim SH, Kim SM, Vincent A, Ahn SW, Hong YH, Park KS, Sung JJ, Lee KW.

J Neurol. 2010 Jun;257(6):920-5. doi: 10.1007/s00415-009-5438-2. Epub 2010 Jan 6.

PMID:
20049472
8.

Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India.

Jain RS, Kumar S, Mathur T, Tejwani S.

Clin Neurol Neurosurg. 2016 Sep;148:5-12. doi: 10.1016/j.clineuro.2016.06.011. Epub 2016 Jun 15.

PMID:
27348743
9.

Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.

Lechner C, Baumann M, Hennes EM, Schanda K, Marquard K, Karenfort M, Leiz S, Pohl D, Venkateswaran S, Pritsch M, Koch J, Schimmel M, Häusler M, Klein A, Blaschek A, Thiels C, Lücke T, Gruber-Sedlmayr U, Kornek B, Hahn A, Leypoldt F, Sandrieser T, Gallwitz H, Stoffels J, Korenke C, Reindl M, Rostásy K.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):897-905. doi: 10.1136/jnnp-2015-311743. Epub 2015 Dec 8.

PMID:
26645082
10.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):281.

11.

[A clinical analysis of onset of high-risk demyelinating events in patients with neuromyelitis optica].

Jia H, Ye J, Zhao X, He F, Li K, Liu Y.

Zhonghua Nei Ke Za Zhi. 2015 Apr;54(4):322-5. Chinese.

PMID:
26268061
12.

A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.

Park JS, Hwang SJ, Shin JH, Kim DS.

J Neurol Sci. 2013 Nov 15;334(1-2):69-71. doi: 10.1016/j.jns.2013.07.2510. Epub 2013 Jul 31.

PMID:
23953947
13.

The expanded spectrum of neuromyelitis optica: evidences for a new definition.

Lana-Peixoto MA, Callegaro D.

Arq Neuropsiquiatr. 2012 Oct;70(10):807-13. Review.

14.

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.

Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ.

Neurology. 2008 Jan 29;70(5):344-52. Epub 2007 Dec 19.

PMID:
18094334
15.

Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.

Alvarenga MP, Alvarenga RM, Alvarenga MP, Santos AM, Thuler LC.

J Spinal Cord Med. 2012 Jul;35(4):251-5. doi: 10.1179/2045772312Y.0000000019.

16.

[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].

Yun W, Weihua Z, Xiaotun R, Jiuwei L, Xinying Y, Junlan L, Changhong D, Chunhong C, Haitao R, Liying C, Fang F.

Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):268-73. Chinese.

PMID:
26182501
17.

Prominent brainstem symptoms/signs in patients with neuromyelitis optica in a Taiwanese population.

Wang KC, Lee CL, Chen SY, Lin KH, Tsai CP.

J Clin Neurosci. 2011 Sep;18(9):1197-200. doi: 10.1016/j.jocn.2010.12.052. Epub 2011 Jul 18.

PMID:
21764586
19.

Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.

Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ.

JAMA Neurol. 2015 Jan;72(1):81-7. doi: 10.1001/jamaneurol.2014.2137.

20.

[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].

Yang Y, Wu WP, Huang DH, Wu L.

Zhonghua Yi Xue Za Zhi. 2012 Nov 20;92(43):3032-5. Chinese.

PMID:
23328372

Supplemental Content

Support Center